{"disease":{"id":"pediatric-gastroesophageal-reflux-disease","name":"pediatric gastroesophageal reflux disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02442752","title":"Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Takeda","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}